J&J opioid case in Oklahoma worsens outlook for other drug companies- STAT

J&J opioid case in Oklahoma worsens outlook for other drug companies- STAT

STAT Plus: The J&J opioid case in Oklahoma darkens the outlook for other drug companies

By ED SILVERMAN

PATRICK SISON/AP

"A $572 million verdict against one defendant for one year worth of costs in a state with four million people is not encouraging," wrote one analyst.

READ MORE